An open science pathway for drug marketing authorization-Registered drug approval

PLoS Med. 2021 Aug 9;18(8):e1003726. doi: 10.1371/journal.pmed.1003726. eCollection 2021 Aug.


Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Approval / methods*
  • Drug Approval / organization & administration
  • European Union*
  • Marketing
  • Pharmaceutical Preparations


  • Pharmaceutical Preparations

Grants and funding

This essay was submitted to the Reimagine Biomedical Research for a Healthier Future Essay Challenge sponsored by the Health Research Alliance and PLOS. It has been recommended for publication in PLOS Medicine. The authors will be receiving a $5,000 prize from the Health Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.